Investors
Key figures
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Revenue (MEUR) | 7.1 | 9.4 | 11.0 | 13.1 | 14.3 |
| EBITDA (MEUR) | -1.2 | 0.5 | 1.6 | 2.2 | 2.9 |
| Operative EBITDA (MEUR) | -1.2 | 0.5 | 1.8 | 2.4 | 3.0 |
| Operating profit/loss (MEUR) | -3.2 | -1.5 | 1.1 | 1.8 | 2.6 |
| Profit/loss before taxes (MEUR) | -3.3 | -1.3 | 0.9 | 2.2 | 2.9 |
| Profit/loss for the period (MEUR) | -3.3 | -1.5 | 0.6 | 1.9 | 2.6 |
| Average number of personnel | 45 | 44 | 45 | 44 | 46 |
| Number of personnel at the end of the period | 46 | 41 | 45 | 46 | 46 |
| Equity ratio (%) | 80,8 | 76.3 | 68.3 | 73 | 78.6 |
| Earnings per share (EUR), Undiluted | -0.22 | -0.10 | 0.04 | 0.12 | 0.17 |
| Earnings per share (EUR), Diluted | -0.22 | -0.10 | 0.04 | 0.12 | 0.17 |
| Shareholders' equity per share (EUR) | 0.58 | 0.49 | 0.50 | 0.62 | 0.80 |
© BIOHIT Healthcare Oyj